Cas:55418-52-5 3,4-Methylenedioxybenzylacetone manufacturer & supplier

We serve Chemical Name:3,4-Methylenedioxybenzylacetone CAS:55418-52-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-Methylenedioxybenzylacetone

Chemical Name:3,4-Methylenedioxybenzylacetone
CAS.NO:55418-52-5
Synonyms:3,4-Methylenedioxybenzylacetone;4-[3,4-(Methylenedioxy)phenyl]-2-butanone;2-Butanone, 4- (1,3-benzodioxol-5-yl)-;2-Butanone, 4-(3,4-(methylenedioxy)phenyl)-;2-Butanone, 4-[3,4-(methylenedioxy)phenyl]-;MFCD00016910;EINECS 259-630-1;2-Butanone, 4-(1,3-benzodioxol-5-yl)-;4-(1,3-Benzodioxol-5-yl)-2-butanone;4-(1,3-benzodioxol-5-yl)butan-2-one;4-(3,4-Methylenedioxyphenyl)-2-butanone;4-(3,4-(Methylenedioxy)phenyl)-2-butanone
Molecular Formula:C11H12O3
Molecular Weight:192.211
HS Code:2932999099

Physical and Chemical Properties:
Melting point:49-54 °C(lit.)
Boiling point:294.5±9.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.539
PSA:35.53000
Exact Mass:192.078644
LogP:1.53

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3,4-Methylenedioxybenzylacetone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(3,4-(Methylenedioxy)phenyl)-2-butanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Butanone, 4-[3,4-(methylenedioxy)phenyl]- Use and application,4-(3,4-Methylenedioxyphenyl)-2-butanone technical grade,usp/ep/jp grade.


Related News: But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. 3,4-Methylenedioxybenzylacetone manufacturer Most of California’s COVID-19 restrictions were lifted on Tuesday and the nation’s most populous state is poised to come roaring back,” according to Gov. Gavin Newsom.
State social distancing rules and capacity limits at restaurants, bars, supermarkets, gyms, stadiums and other locations have been rolled back, and masks will no longer be required for vaccinated people in most settings, the Associated Press reported.
However, businesses and counties can still require them.
In March 2020, California became the first in the United States to impose a statewide shutdown. More people tested positive for the virus (3.8 million to date) and more people died (more than 63,000) in California than anywhere else in the country, but it had a lower per capita death rate than most others, the AP reported.
California now has one of the lowest infection rates (below 1%) in the U.S.
That low rate and a rising number of vaccinated residents — over 70% of adults have had at least one shot — led Newsom to announce in April that most pandemic restrictions would be lifted June 15, the AP reported.
However, the governor has repeatedly said the reopening doesn’t mean the pandemic is over, and some public health measures will still be in place for “mega events. 3,4-Methylenedioxybenzylacetone supplier But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. 3,4-Methylenedioxybenzylacetone vendor Most of California’s COVID-19 restrictions were lifted on Tuesday and the nation’s most populous state is poised to come roaring back,” according to Gov. Gavin Newsom.
State social distancing rules and capacity limits at restaurants, bars, supermarkets, gyms, stadiums and other locations have been rolled back, and masks will no longer be required for vaccinated people in most settings, the Associated Press reported.
However, businesses and counties can still require them.
In March 2020, California became the first in the United States to impose a statewide shutdown. More people tested positive for the virus (3.8 million to date) and more people died (more than 63,000) in California than anywhere else in the country, but it had a lower per capita death rate than most others, the AP reported.
California now has one of the lowest infection rates (below 1%) in the U.S.
That low rate and a rising number of vaccinated residents — over 70% of adults have had at least one shot — led Newsom to announce in April that most pandemic restrictions would be lifted June 15, the AP reported.
However, the governor has repeatedly said the reopening doesn’t mean the pandemic is over, and some public health measures will still be in place for “mega events. 3,4-Methylenedioxybenzylacetone factory But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies.